- CEO
- Alvaro Daniel Alberttis
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 80 NE 4th Avenue Delray Beach FL United States of America
- IPO Date
- Dec 30, 2015
- Business
- Exactus, Inc. (EXDI) operates as a farmer and manufacturer of hemp-derived phytocannabinoid products; it produces industrial hemp from farms in Oregon and sells CBD products through its Green Goddess brand and third-party resellers; core offerings encompass hemp-derived ingredients including CBD, CBG, CBC, and CBN, as well as feminized hemp genetics and seeds that adhere to stringent quality and traceability standards. The company engages in extraction and manufacturing via cGMP-certified facilities, targeting sectors such as beverages, food, pets, cosmetics, wellness, and pharmaceuticals. Founded prior to 2019 and headquartered in Delray Beach, Florida, Exactus conducts operations primarily in the United States with a focus on sustainable agricultural practices. In June 2021, Exactus completed a reverse merger acquisition by Panacea Life Sciences Holdings, Inc. for $54.5 million, involving the issuance of substantial preferred and common stock; the combined entity adopted the Panacea Life Sciences Holdings name (ticker: PLSH) and shifted leadership to Leslie Buttorff as CEO while retaining CBD operations. Subsequent developments under the rebranded structure include expansion into diversified plant-based products such as Nitro Kava, Kratom, mushrooms, VAPE items, beverages, and natural remedies across PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure, and PANA Life brands; recent initiatives feature a July 2023 diversification plan into vegan nutraceuticals, organic wellness products, and investigative research on psilocybin and psychedelics, alongside premium skincare launches with new CBD and CBG formulations.